Hyperfine, Inc. (HYPR)
0.8375
+0.02
(+2.98%)
USD |
NASDAQ |
Sep 28, 16:00
0.8375
0.00 (0.00%)
After-Hours: 20:00
Hyperfine Cash from Operations (Annual) : -27.95M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -27.95M |
| December 31, 2024 | -38.77M |
| December 31, 2023 | -41.81M |
| Date | Value |
|---|---|
| December 31, 2022 | -72.34M |
| December 31, 2021 | -47.18M |
| December 31, 2020 | -21.52M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Abbott Laboratories | 9.566B |
| AngioDynamics, Inc. | 3.089M |
| Alphatec Holdings, Inc. | 45.23M |
| AtriCure, Inc. | 57.33M |
| Baxter International, Inc. | 845.00M |